// App-Quantinova.ai

POS0728 (2022) : ASSOCIATION BETWEEN TREATMENT GOAL ACHIEVEMENT AND GRIT PERSONALITY CHARACTERISTICS OF ATTENDING PHYSICIAN IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY

Researchers

Presenter

  • K. E. Sada

Principal Investigators

  • K. Shidahara

  • S. Nawachi

  • Y. Katayama

  • Y. Asano

  • K. Hayashi

  • K. Ohashi

  • E. Katsuyama

  • T. Katsuyama

  • M. Narazaki

  • Y. Matsumoto

  • N. Oguro

  • Y. Ishikawa

  • N. Sakurai

  • C. Hidekawa

  • R. Yoshimi

  • T. Ichikawa

  • D. Kishida

  • Y. Shimojima

  • N. Kurita

  • N. Yajima

Medical Centers

  • Kochi Medical School, Department of Clinical Epidemiology, Nankoku, Japan

  • Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama, Japan

  • The Jikei University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Department of Endoscopy, Tokyo, Japan

  • School of Medicine, University of Occupational and Environmental Health, The First Department of Internal Medicine, Kitakyushu, Japan

  • Yokohama City University Graduate School of Medicine, Department of Stem Cell and Immune Regulation, Yokohama, Japan

  • Shinshu University School of Medicine, Department of Medicine (Neurology and Rheumatology), Matsumoto, Japan

  • Fukushima Medical University, Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima, Japan

  • Fukushima Medical University, Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Pfizer Inc

Result

  • N/A